A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.
New nanoparticles can perform gene editing in the lungs, MIT News
New era in genetic medicines beckons as Aera arrives on scene
Michaela Nicole Prado Larrea on LinkedIn: Investigation of the enhanced antitumour potency of STING agonist after…
Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models
Nanoparticles for gene therapy improve, MIT News
Lipid nanoparticle-enabled gene editing in the lung via inhalation
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing
Gene Editing: Exploring the Boundaries of Innovation and Ethics by Joshua T. Berglan, by Joshua T Berglan 'The World's Mayor', Feb, 2024
New type of nanoparticle can deliver messenger RNA encoding useful proteins to the lungs
Novel nanoparticles deliver CRISPR gene editing tools into the cell with much higher efficiency
New nanoparticles can perform gene-editing in the lungs
